*Please see sample requirement information sheet for sample collection, storage, and shipment details. *Test adapted to other body fluids, such as pleural effusion, cerebrospinal fluid, aqueous humor, and urine (Please consult for sample collection requirements). Copyright © 2025. GENESEEQ Technology Inc. All rights reserved.

MINIMAL RESIDUAL DISEASE SURVEILLANCE Perioperative Testing Strategy Adjuvant Treatment NeoAdjuvant Treatment Adjuvant Treatment Post-Adjuvant Treatment Dynamic Monitor Tumor Recurrence & Metastasis The MRD baseline tumor assessment utilizes the Geneseeq Plus panel ctDNA profiling of mutational hotspots in 2365 cancer-related genes before surgery and at three time points post-surgery Normal control (white blood cells) profiling at baseline Turnaround Time Report expected in 5-7days from sample receipt. ‡ Variant Types Tumor Mutational Burden (TMB) IVD/RUO Reagent Kits Kits contain reagents required...